Clinical application and effectiveness of low-density lipoprotein apheresis in the treatment of coronary artery disease

Therapeutic Apheresis

Volumn 1, Issue 3, 1997, Pages 253-254

  Daida, Hiroyuki ^a   Yamaguchi, Hiroshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Lipoprotein (a); Low density lipoprotein apheresis; Progression of coronary atherosclerosis; Restenosis

Indexed keywords

ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANGIOCARDIOGRAPHY; APHERESIS; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DRUG COMBINATION; FOLLOW UP; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; PROSPECTIVE STUDY; RADIOGRAPHY; RECURRENT DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTILIPEMIC AGENTS; BLOOD COMPONENT REMOVAL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0031195723     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00147.x     Document Type: Article

References (7)

1. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-622.
2. Yokoyama S. Treatment of hypercholesterolemia by chemical adsorption of lipoproteins. J Clin Apheresis 1988;4:66-71.
3. Homma Y, Mikami Y, Tamachi H, Nakaya N, Nakamura H, Goto Y. Comparison of selectivity of LDL removal by double filtration and dextransulfate cellulose column plasmapheresis and changes of subfractionated plasma lipoprotein after plasmapheresis in heterozygous familial hypercholesterolemia. Metabolism 1987;36:419-25.
4. Nishimura S, Yamaguchi Y. Regression of coronary atherosclerosis by intensive lipid lowering therapy with combined LDL-apheresis and drugs in familial hypercholesterolemia: Japan LDL-Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS). Circulation 1994;90(suppl):1-510.
5. Daida H, Lee YJ, Yokoi H, Kanoh T, Ishiwata S, Kato K, Nishikawa H, Takatsu F, Kato H, Kutsumi Y, Yamada N, Noma A, Yamaguchi H. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Am J Cardiol 1994;73:1037-10.
6. Koizumi J, Koizumi I, Uno Y, Inazu A, Kajinami K, Haraki T, Yagi K, Kamon N, Miyamoto S, Takegoshi T, Mabuchi H, Takeda R, Tani N, Takada S. Reduction of lipoprotein (a) by LDL-apheresis using dextran sulfate cellulose column in patients with familial hypercholesterolemia. Atherosclerosis 1993;100:65-74.
7. Hearn JA, Donohue BC, Ba'albaki H, Douglas JS, King SB III, Lembo MJ, Roubin GS, Sgoutas DS. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;69: 736-9.